MedTrace Logo

The Biomarkers Of RIsk of Colorectal Cancer (BORICC) Follow-Up (BFU) Study

NCT04005742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2019-07-02

No results posted yet for this study

Summary

Worldwide, colorectal cancer is the 3rd most common cancer; risk increases with age and is modified by lifestyle factors notably diet, physical activity and obesity. The BORICC Follow-Up (BFU) Study is a 12+ year follow-up of participants recruited to the Biomarkers of Risk of Colon Cancer (BORICC) Study. This longitudinal study will investigate associations between ageing and lifestyle factors and a panel of molecular biomarkers linked with colorectal cancer risk.

Conditions

Sponsors & Collaborators

  • Northumbria Healthcare NHS Foundation Trust

    collaborator OTHER

  • Newcastle University

    lead OTHER

Principal Investigators

  • John Mathers · Newcastle University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-13
Primary Completion
2018-06-08
Completion
2018-06-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04005742 on ClinicalTrials.gov